Table 1 Clinical characteristics of lymphoma patients (n = 80)

Median age (range)

58 (18 ~ 85)

Received Treatment

Male/Female

41/39

 Anti-CD20 + Chemo

47

Diagnosis

 Anti-CD20 + BTKi

2

 DLBCL

37

 Anti-CD20 + Chemo + BTKi

9

 TCL

13

 BTKi alone

1

 MZL

8

 ASCT

12

 HL

7

Severity of COVID-19

 MCL

6

 Mild

57

 FL

5

 Moderate

16

 OTL

4

 Severe/Critical

7

Risk stratification (NCCN-IPI)

Treatment of COVID-19

 Low

26

 Symptomatic treatment

57

 Moderate

25

 Oxygen therapy/steroids/antiviral

23

 High

29

 mAb/convalescent plasma

3

Vaccination history

56

 ICU admission

2